Quintijn Bonnez: How ADAMTS13 Conformation May Predict Early Relapse and Guide Pre-Emptive Therapy
Quintijn Bonnez, Early-Career Board Member at Belgian Society on Thrombosis and Haemostasis, shared a post on LinkedIn about a recent article he and Karen Vanhoorelbeke co-authored, published in Belgian Journal of Hematology, adding:
“Have you already received your copy ?
Excited to see our Hematology review covered on the latest edition of the Belgian Journal of Hematology.
In this review, the evidence for open ADAMTS13 as a highly specific biomarker for both acute and subclinical iTTP was summarized. Beyond its diagnostic value, we highlighted how ADAMTS13 conformation may contribute to early relapse risk prediction and help guide pre-emptive therapeutic interventions.
Key messages for clinical practice:
- ADAMTS13 conformation adds diagnostic value beyond testing Enzyme activity.
- Distinct, open ADAMTS13 is characteristic for iTTP.
- Closed ADAMTS13 is preserved in healthy individuals and non-iTTP clinical conditions.
This exciting work continues to bridge fundamental protein Biology with clinical decision-making, bringing us one step closer to improved diagnosis and patient monitoring.”
Title: Distinct open ADAMTS13 for diagnosing and monitoring acute and subclinical immune-mediated thrombotic thrombocytopenic purpura
Authors: Quintijn Bonnez, Karen Vanhoorelbeke
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering